miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.
Bresin A, Callegari E, D'Abundo L, Cattani C, Bassi C, Zagatti B, Narducci MG, Caprini E, Pekarsky Y, Croce CM, Sabbioni S, Russo G, Negrini M.
Bresin A, et al. Among authors: narducci mg.
Oncotarget. 2015 Aug 14;6(23):19807-18. doi: 10.18632/oncotarget.4415.
Oncotarget. 2015.
PMID: 26090867
Free PMC article.